<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-ijms-22-01566">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Miranda-Gon√ßalves</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Granja</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Martinho</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Honavar</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Pojo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Costa</surname>
    <given-names>B.M.</given-names>
   </name>
   <name>
    <surname>Pires</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Pinheiro</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Cordeiro</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bebiano</surname>
    <given-names>G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas</article-title>
  <source>Oncotarget</source>
  <year>2016</year>
  <volume>7</volume>
  <fpage>46335</fpage>
  <lpage>46353</lpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.10114</pub-id>
  <pub-id pub-id-type="pmid">27331625</pub-id>
 </element-citation>
</ref>
